NxStage Medical (NXTM) : 6 brokerage houses believe that NxStage Medical (NXTM) is a Strong Buy at current levels. Zacks Investment Research suggests a Hold with a rank of 3. 1 others believe that the stock has run up ahead of its fundamentals and advise a Strong Sell on the stock.The median of all the 7 Wall Street Analysts endorse the stock as a Buy with a rating of 1.57.
NxStage Medical (NXTM) : 5 Wall Street analysts covering NxStage Medical (NXTM) believe that the average level the stock could reach for the short term is $25.4. The maximum price target given is $30 and the minimum target for short term is around $21, hence the standard deviation is calculated at $3.36.
For the current week, the company shares have a recommendation consensus of Buy.
NxStage Medical (NASDAQ:NXTM): The stock opened at $22.34 on Wednesday but the bulls could not build on the opening and the stock topped out at $22.54 for the day. The stock traded down to $21.78 during the day, due to lack of any buying support eventually closed down at $22.01 with a loss of -1.63% for the day. The stock had closed at $22.37 on the previous day. The total traded volume was 1,034,463 shares.
NxStage Medical, Inc. is a medical device company. The Company is engaged in the development, manufacturing and marketing of products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Companys products include the System One, Streamline Blood Tubing Sets and AV Fistula and Apheresis Needles. Its primary product, the System One, is a small, portable, easy-to-use hemodialysis system. It is designed to deliver the therapeutic flexibility and clinical benefits associated with traditional dialysis machines in a smaller, portable, easy-to-use form that can be used by healthcare professionals and trained lay users alike in a variety of settings, including patient homes, as well as more traditional care settings such as hospitals and dialysis centers. The Company operates in three reportable business segments: System One, In-Center and Services.